Connection

Kenneth Tew to Tumor Cells, Cultured

Back to Details
This is a "connection" page, showing publications Kenneth Tew has written about Tumor Cells, Cultured.
Kenneth Tew
Connection Strength
1.359
Tumor Cells, Cultured
  1. Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program. Mol Pharmacol. 1996 Jul; 50(1):149-59.
    View in: PubMed
    Score: 0.116
  2. Cytotoxicity and DNA damaging effects of a new nitrosourea, fotemustine, diethyl- 1-(3-(2-chloroethyl)-3-nitrosoureido) ethylphosphonate-S10036. Anticancer Res. 1989 Nov-Dec; 9(6):1617-22.
    View in: PubMed
    Score: 0.073
  3. Identification of a glutathione S-transferase associated with microsomes of tumor cells resistant to nitrogen mustards. Biochem Pharmacol. 1989 Jun 15; 38(12):1915-21.
    View in: PubMed
    Score: 0.071
  4. Glutathione, glutathione S-transferases, and related redox enzymes in Adriamycin-resistant cell lines with a multidrug resistant phenotype. Cancer Commun. 1989; 1(2):133-9.
    View in: PubMed
    Score: 0.069
  5. Human ATP-binding cassette transporter-2 (ABCA2) positively regulates low-density lipoprotein receptor expression and negatively regulates cholesterol esterification in Chinese hamster ovary cells. Biochim Biophys Acta. 2004 Jul 05; 1683(1-3):89-100.
    View in: PubMed
    Score: 0.051
  6. Tumor cell responses to a novel glutathione S-transferase-activated nitric oxide-releasing prodrug. Mol Pharmacol. 2004 May; 65(5):1070-9.
    View in: PubMed
    Score: 0.050
  7. Identification of a novel first exon of the human ABCA2 transporter gene encoding a unique N-terminus. Biochim Biophys Acta. 2004 Apr 16; 1678(1):22-32.
    View in: PubMed
    Score: 0.050
  8. Reciprocal regulation of expression of the human adenosine 5'-triphosphate binding cassette, sub-family A, transporter 2 (ABCA2) promoter by the early growth response-1 (EGR-1) and Sp-family transcription factors. Nucleic Acids Res. 2003 Feb 01; 31(3):1097-107.
    View in: PubMed
    Score: 0.046
  9. Integration of amplified differential gene expression (ADGE) and DNA microarray. IUBMB Life. 2002 Dec; 54(6):335-8.
    View in: PubMed
    Score: 0.045
  10. Efficacy of a glutathione S-transferase pi-activated prodrug in platinum-resistant ovarian cancer cells. Mol Cancer Ther. 2002 Oct; 1(12):1089-95.
    View in: PubMed
    Score: 0.045
  11. Nuclear PFKP promotes CXCR4-dependent infiltration by T cell acute lymphoblastic leukemia. J Clin Invest. 2021 08 16; 131(16).
    View in: PubMed
    Score: 0.042
  12. Cloning and characterization of human adenosine 5'-triphosphate-binding cassette, sub-family A, transporter 2 (ABCA2). Cancer Res. 2001 Apr 15; 61(8):3339-47.
    View in: PubMed
    Score: 0.041
  13. Cellular response to a glutathione S-transferase P1-1 activated prodrug. Mol Pharmacol. 2000 Jul; 58(1):167-74.
    View in: PubMed
    Score: 0.038
  14. Genomic sequence of human glyoxalase-I: analysis of promoter activity and its regulation. Gene. 1999 Nov 15; 240(1):149-55.
    View in: PubMed
    Score: 0.037
  15. Coordinate changes in expression of protective genes in drug-resistant cells. Chem Biol Interact. 1998 Apr 24; 111-112:199-211.
    View in: PubMed
    Score: 0.033
  16. Amplification of the ATP-binding cassette 2 transporter gene is functionally linked with enhanced efflux of estramustine in ovarian carcinoma cells. Cancer Res. 1998 Apr 01; 58(7):1332-7.
    View in: PubMed
    Score: 0.033
  17. MYC Inhibition Depletes Cancer Stem-like Cells in Triple-Negative Breast Cancer. Cancer Res. 2017 12 01; 77(23):6641-6650.
    View in: PubMed
    Score: 0.032
  18. Importance of glutathione and associated enzymes in drug response. Oncol Res. 1997; 9(6-7):295-302.
    View in: PubMed
    Score: 0.030
  19. Promoter analysis of a human dihydrodiol dehydrogenase. Biochem Biophys Res Commun. 1996 Nov 12; 228(2):524-9.
    View in: PubMed
    Score: 0.030
  20. Effects of chronic ethacrynic acid exposure on glutathione conjugation and MRP expression in human colon tumor cells. Biochem Biophys Res Commun. 1996 May 06; 222(1):111-5.
    View in: PubMed
    Score: 0.029
  21. Influence of ethacrynic acid on glutathione S-transferase pi transcript and protein half-lives in human colon cancer cells. Biochem Pharmacol. 1995 Oct 12; 50(8):1233-8.
    View in: PubMed
    Score: 0.028
  22. Modulation of P-glycoprotein activity by estramustine is limited by binding to plasma proteins. Cancer. 1995 May 15; 75(10):2597-604.
    View in: PubMed
    Score: 0.027
  23. Interaction of an estramustine photoaffinity analogue with cytoskeletal proteins in prostate carcinoma cells. Mol Pharmacol. 1994 Nov; 46(5):866-72.
    View in: PubMed
    Score: 0.026
  24. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res. 1994 Aug 15; 54(16):4313-20.
    View in: PubMed
    Score: 0.026
  25. cDNA and deduced amino acid sequences of a human colon dihydrodiol dehydrogenase. Biochim Biophys Acta. 1994 Jun 28; 1186(1-2):129-32.
    View in: PubMed
    Score: 0.025
  26. P-glycoprotein binding and modulation of the multidrug-resistant phenotype by estramustine. J Natl Cancer Inst. 1994 May 04; 86(9):688-94.
    View in: PubMed
    Score: 0.025
  27. Overproduction of a 37.5-kDa cytosolic protein structurally related to prostaglandin F synthase in ethacrynic acid-resistant human colon cells. Mol Pharmacol. 1993 Jun; 43(6):845-53.
    View in: PubMed
    Score: 0.023
  28. Time course of glutathione S-transferase elevation in Walker mammary carcinoma cells following chlorambucil exposure. Biochem Pharmacol. 1993 Feb 09; 45(3):683-90.
    View in: PubMed
    Score: 0.023
  29. Combined antimicrotubule activity of estramustine and taxol in human prostatic carcinoma cell lines. Cancer Res. 1992 Aug 15; 52(16):4433-40.
    View in: PubMed
    Score: 0.022
  30. Resistance to the antimitotic drug estramustine is distinct from the multidrug resistant phenotype. Br J Cancer. 1991 Aug; 64(2):267-73.
    View in: PubMed
    Score: 0.021
  31. The effects of estramustine on metaphase and anaphase in DU 145 prostatic carcinoma cells. Eur J Cell Biol. 1991 Apr; 54(2):268-76.
    View in: PubMed
    Score: 0.020
  32. Purification of glutathione S-transferases from rat liver and Walker 256 mammary carcinoma cells by high-performance liquid chromatography and a glutathione affinity column. J Chromatogr. 1988 Dec 29; 434(1):83-93.
    View in: PubMed
    Score: 0.017
  33. Ethacrynic acid and piriprost as enhancers of cytotoxicity in drug resistant and sensitive cell lines. Cancer Res. 1988 Jul 01; 48(13):3622-5.
    View in: PubMed
    Score: 0.017
  34. Mitoxantrone resistance in a small cell lung cancer cell line is associated with ABCA2 upregulation. Br J Cancer. 2004 Jun 14; 90(12):2411-7.
    View in: PubMed
    Score: 0.013
  35. Molecular modes of action of artesunate in tumor cell lines. Mol Pharmacol. 2003 Aug; 64(2):382-94.
    View in: PubMed
    Score: 0.012
  36. Double high-dose chemotherapy with stem cell rescue (HD-SCR) in patients with breast cancer - effect of sequence. Cancer Chemother Pharmacol. 2000; 45(3):239-46.
    View in: PubMed
    Score: 0.009
  37. Estramustine resistance correlates with tau over-expression in human prostatic carcinoma cells. Int J Cancer. 1998 Aug 12; 77(4):626-31.
    View in: PubMed
    Score: 0.008
  38. Tumor efficacy and bone marrow-sparing properties of TER286, a cytotoxin activated by glutathione S-transferase. Cancer Res. 1998 Jun 15; 58(12):2568-75.
    View in: PubMed
    Score: 0.008
  39. Association of estramustine resistance in human prostatic carcinoma cells with modified patterns of tubulin expression. Biochem Pharmacol. 1998 Feb 01; 55(3):325-31.
    View in: PubMed
    Score: 0.008
  40. Increase of beta(III)- and beta(IVa)-tubulin isotopes in human prostate carcinoma cells as a result of estramustine resistance. Cancer Res. 1996 Jun 01; 56(11):2584-9.
    View in: PubMed
    Score: 0.007
  41. Isozyme-specific glutathione S-transferase inhibitors potentiate drug sensitivity in cultured human tumor cell lines. Cancer Chemother Pharmacol. 1996; 37(4):363-70.
    View in: PubMed
    Score: 0.007
  42. Modulation of glutathione and related enzymes in reversal of resistance to anticancer drugs. Hematol Oncol Clin North Am. 1995 Apr; 9(2):383-96.
    View in: PubMed
    Score: 0.007
  43. Interaction of forskolin with the P-glycoprotein multidrug transporter. Biochemistry. 1991 Aug 27; 30(34):8371-9.
    View in: PubMed
    Score: 0.005
  44. Determinants of drug response in a cisplatin-resistant human lung cancer cell line. Jpn J Cancer Res. 1990 May; 81(5):527-35.
    View in: PubMed
    Score: 0.005
  45. Estramustine binds a MAP-1-like protein to inhibit microtubule assembly in vitro and disrupt microtubule organization in DU 145 cells. J Cell Biol. 1988 Dec; 107(6 Pt 2):2647-56.
    View in: PubMed
    Score: 0.004
  46. Immunofluorescent studies of the anti-microtubule effects of the anti-cancer drug estramustine. Anticancer Res. 1987 Nov-Dec; 7(6):1165-71.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.